Add to ORKGMale breast cancer is rare disease and it represents 1 % breast cancer. Invasive ductal cancer dominates in histology with 10 % portion in situ carcinoma. Other histology types are extraordinary. Female breast carcinoma has different diversion in molecular subtype than male carcinoma, which is predominant hormonal sensitive. Mastectomy is procedure of choice with sentinel node biopsy or axillary dissection in surgery. Radiotherapy is used after breast conservative procedure. Indication after mastectomy depends on stage of the carcinoma. Hormonal therapy is mainly applied in adjuvant therapy and mostly with Tamoxifen. Male carcinoma is very similar with female carcinoma but is not identical. Medical care come out from experience with treatme...
Male breast cancer is a rare disease with unclear etiology. Its incidence is about 0.5-1%. Usually, ...
Everybody is born with the mammary gland. Mammary gland development occurs through various stages th...
Diagnosis and treatment modalities for female breast cancer have developed spectacularly in recent y...
Male breast cancer (MBC) is a rare disease. However, as global populace ages, there is a trend to MB...
Aim: Male breast cancer is a rare disease representing 1% of all breast cancers and less than 1% of...
Breast cancer (BC) is an epithelial neoplastic disease that usually begins in the ducts or lobules o...
Aim: Male breast carcinomas are very rare tumors. In this study, we aimed to evaluate the male pati...
Carcinoma of the male breast (MBC) is an uncommon phenomenon, accounting for <1% of all malignanc...
The earliest reference to breast cancer (BC) in men dates from 3000-2500 BCE, on an Egyptian papyrus...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the incidence...
Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the incidence...
Male breast cancer (MaIeBC) is a rare disease, accounting for <1% of all male tumors. During the las...
Male breast cancer is a rare disease with unclear etiology. Its incidence is about 0.5-1%. Usually, ...
Everybody is born with the mammary gland. Mammary gland development occurs through various stages th...
Diagnosis and treatment modalities for female breast cancer have developed spectacularly in recent y...
Male breast cancer (MBC) is a rare disease. However, as global populace ages, there is a trend to MB...
Aim: Male breast cancer is a rare disease representing 1% of all breast cancers and less than 1% of...
Breast cancer (BC) is an epithelial neoplastic disease that usually begins in the ducts or lobules o...
Aim: Male breast carcinomas are very rare tumors. In this study, we aimed to evaluate the male pati...
Carcinoma of the male breast (MBC) is an uncommon phenomenon, accounting for <1% of all malignanc...
The earliest reference to breast cancer (BC) in men dates from 3000-2500 BCE, on an Egyptian papyrus...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the incidence...
Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the incidence...
Male breast cancer (MaIeBC) is a rare disease, accounting for <1% of all male tumors. During the las...
Male breast cancer is a rare disease with unclear etiology. Its incidence is about 0.5-1%. Usually, ...
Everybody is born with the mammary gland. Mammary gland development occurs through various stages th...
Diagnosis and treatment modalities for female breast cancer have developed spectacularly in recent y...